<DOC>
	<DOCNO>NCT00001733</DOCNO>
	<brief_summary>This screening protocol design help recruit patient National Eye Institute ( NEI ) study retina , diabetic retinopathy macular degeneration . Patients must meet specific criterion research study , protocol serf first step admit patient retinal disease study . Candidates undergo medical history comprehensive eye examination . The eye examination include dilation pupil fully examine retina . In study , photograph eye require . This do use fluorescein angiography . In procedure , dye call sodium fluorescein inject blood stream vein . After dye reach blood vessel eye , photograph take retina . Other diagnostic procedure may include physical examination , questionnaire , routine laboratory test standard specialized test , need . When screen complete , patient inform option participate study . Patients ineligible current study inform alternative treatment option . No treatment offer protocol .</brief_summary>
	<brief_title>Screening Studies Retinovascular Diseases</brief_title>
	<detailed_description>This protocol design screen patient presumed retinovascular disease . It serve first step individual may eligible wish participate National Eye Institute clinical research study retinovascular disease . Each individual thoroughly evaluate screen process determine suitable candidate inclusion National Eye Institute ongoing study . The screening evaluation include past current medical history appropriate physical examination , namely comprehensive eye exam . Other routine diagnostic procedure test may also complete order help determine subject 's eligibility . These test procedure minimal risk describe detail section III : `` Study Procedures . '' Once screen process complete eligibility assess , subject inform option participate one current clinical research study . If appropriate protocol identify , recommendation treatment option may give individual , primary doctor , refer physician .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<criteria>INCLUSION/EXCLUSION CRITERIA Inclusion exclusion criterion vary particular protocol patient screen . In addition diagnosis currently study , subject unknown condition require establishment diagnosis may eligible inclusion study . All study retinovascular disease require subject minimum age 18 year men woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2, 2008</verification_date>
	<keyword>Diabetic Retinopathy</keyword>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Neovascularization</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>Retinal Disease</keyword>
	<keyword>Diabetes</keyword>
</DOC>